Lawyers of the Legal Alliance Company have prepared a review "Red flags of pharma business in Ukraine", which is designed to provide practical assistance to companies that are interested in establishing pharmaceutical business in Ukraine, but do not yet have an experience in the market of our country.
The review undoubtedly will also be useful to managers, who supervise the Ukrainian market or are responsible for its individual segments, and are not residents of Ukraine, as well as to managers, who were recently appointed to Ukraine, but do not have any previous experience here.
Red flags - is a handbook which contains a summary of the most problematic issues of the functioning of the pharmaceutical business, that we, as specialized legal advisers of the pharmaceutical industry with the twenty years of experience, do not recommend to disregard.
On the pages of the handbook our lawyers have arranged red flags in areas such as competition law, building distribution scheme, providing discounts, bonuses to distributors, anti-corruption legislation, system of Compliance, advertising and promotions, import licensing of medicinal products, registration of medicinal products, as well as intellectual property.
Employees of pharmaceutical companies can get a free guide by joining our group «Pharmaceutical law | Ukraine & CIS» in the social network LinkedIn following the link below: https://www.linkedin.com/groups?home=&gid=7455011&trk=my_groups-tile-grp.
The handbook will show you the pitfalls, by avoiding which you may confidently lead your business to success. If you need a reliable guide - we always remain at your disposal and are happy to contribute to the development of your business in the Ukrainian market.
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.
